13F Pro Quality Score

49.4/100

Rank #1,507 of 2,879 stocks

View Materials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

26.2/100

Profitability

46.1/100

Balance Sheet

59.5/100

Earnings Quality

18.4/100

Free Cash Flow

28.3/100

Institutional Flow

86.9/100

Revenue Scale

85.5/100

Dilution Risk

73.0/100

EMN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for EASTMAN CHEMICAL CO (EMN), a Materials sector company. 13F Pro's AI-powered ranking engine scores EMN at 49.4/100 on a 32-signal composite quality model, placing it at rank #1,507 of 2,879 stocks — the bottom half of the AI-ranked universe. EMN scores in the top quartile across institutional flow (86.9), revenue scale (85.5). Areas of concern include earnings quality (18.4) and revenue growth (26.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), EASTMAN CHEMICAL CO reports quarterly revenue of $2.2B, net income of $107.0M, an operating margin of 6.3%. Top institutional holders of EMN by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. EMN trades on the NYSE exchange and files with the SEC under CIK 915389. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EMN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for EASTMAN CHEMICAL CO directly from SEC EDGAR. EASTMAN CHEMICAL CO's 13F Pro composite quality score has ranged between 8 and 65 since 2021, currently 49.4 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.

Revenue

Q1 2026

$2.2B

Net Income

Q1 2026

$107.0M

Free Cash Flow

Q1 2026

$-240.0M

Operating Margin

Q1 2026

6.3%

ROIC

Q1 2026

1.3%

D/E Ratio

Q1 2026

0.87

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-12.9% YoY
$9.21BFY 2023
FY20 $8.47BFY21 $10.48BFY22 $10.58BFY23 $9.21B

Net Income

+12.7% YoY
$894.0MFY 2023
FY20 $478.0MFY21 $857.0MFY22 $793.0MFY23 $894.0M

Operating Income

FY 2023
FY20 FY21 FY22 FY23

EPS (Diluted)

+18.0% YoY
$7.49FY 2023
FY20 $3.50FY21 $6.25FY22 $6.35FY23 $7.49

Total Assets

-0.2% YoY
$14.63BFY 2023
FY20 $16.08BFY21 $15.52BFY22 $14.67BFY23 $14.63B

Total Debt

-5.9% YoY
$4.85BFY 2023
FY20 $5.62BFY21 $5.16BFY22 $5.15BFY23 $4.85B

Op. Cash Flow

+40.9% YoY
$1.37BFY 2023
FY20 $1.46BFY21 $1.62BFY22 $975.0MFY23 $1.37B

AI Insight: EMN Financial Trends

Revenue declined 8% year-over-year to $2.18B in Q1 2026, while net income collapsed 41% and operating cash flow turned sharply negative.

Revenue contracted from $2.36B (Q2 2024) to $2.18B (Q1 2026), a cumulative 8% decline over eight quarters.

Net income deteriorated from $230M (Q2 2024) to $107M (Q1 2026), down 53% despite modest revenue stability in recent quarters.

Operating cash flow swung to negative $137M in Q1 2026, the second working-capital decline in three quarters.

Total debt rose to $5.22B (Q1 2026) from $4.79B (Q4 2025); debt-to-equity now 0.87x, highest in the dataset.

Profitability has compressed sharply: Q1 2026 net income ($107M) is less than half Q4 2024 levels ($330M).

AI Insight: EMN Ratio Trends

Eastman's profitability metrics collapsed through 2025, with operating margin falling from 12.2% (Q2 2024) to 0.6% (Q4 2025), signaling severe operational distress.

Operating margin cratered from 12.2% in Q2 2024 to 0.6% in Q4 2025, lowest on record. ROIC declined 10.4pp over same span.

TTM ROIC stands at 4.0% versus 10.8% in Q2 2024—a 68% decline in capital efficiency. ROE halved to 6.6% TTM from 16.4% two years prior.

Leverage held steady; D/E improved slightly to 0.80 in Q4 2025 from 0.89 in mid-2024, but weak profitability undermines debt serviceability.

Q4 2025 operating margin of 0.6% represents near-breakeven operations. Recovery trajectory unclear; Q1 2026 modest rebound to 6.2% insufficient.

Net profit margin volatile: peaked 14.7% in Q4 2024, then deteriorated to 2.1% in Q3 2025. Current 4.9% TTM suggests ongoing margin pressure.

Get alerted when EMN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for EASTMAN CHEMICAL CO including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of EMN

Put EMN on your watchlist

Track score changes the day EASTMAN CHEMICAL CO files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is EMN a good stock to buy?

13F Pro's AI-powered analysis of EASTMAN CHEMICAL CO (EMN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EMN are available on the EMN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own EMN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EMN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of EASTMAN CHEMICAL CO's investment landscape.